Skip to main content

Interstitial Chemotherapy with Sustained-Release Polymer Systems for the Treatment of Malignant Gliomas

  • Conference paper
Molecular Neuro-oncology and Its Impact on the Clinical Management of Brain Tumors

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 135))

Abstract

Malignant gliomas remain poorly responsive to conventional treatment consisting of surgical resection followed by external beam radiation therapy. Moreover, systemic chemotherapy has been generally disappointing in prolonging the survival of patients with malignant brain tumors, except for those with anaplastic oligodendrogliomas, where more encouraging results have recently been reported. The significant systemic toxicity associated with the large doses of chemotherapeutic agents required and the poor delivery of anticancer agents to areas of the brain “protected” by the blood-brain barrier are likely responsible for the limited effectiveness of chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brem H, Domb A, Lenartz D, Dureza C, Olivi A, Epstein I (1992) Brain biocompatibility of a biodegradable controlled release polymer consisting of anhydride copolymer of fatty acid dimer and sebacic acid. J Controlled Release 19: 325–330

    Article  CAS  Google Scholar 

  2. Brem H, Mahaley S, Vick NA, Black KL, Schold C, Burger PC, Friedman AH, Ciric IS, Eller TW, Cozzens JW, Kenealy JN (1991) Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74: 441–446

    Article  PubMed  CAS  Google Scholar 

  3. Brem H, Tamargo RJ, Olivi A, Pinn M, Wharam M, Epstein J (1994) Controlled delivery using biodegradable polymers for chemotherapy with and without radiation therapy in the monkey brain. Neurosurg in press

    Google Scholar 

  4. Brem H, Tamargo RJ, Pinn M, Chasin M (1988) Biocompatibility of a BCNU-loaded biodegradable polymer: a toxicity study in primates. American Association of Neurological Surgeons, Toronto, p. 381

    Google Scholar 

  5. Chasin J, Domb A, Ron E, Mathiowitz E, Langer R, Leong K, Laurencin C, Brem H, Grossman S (1990) Polyanhydrides as drug delivery systems In: Chasin M, Langer R (eds) Biodegradable polymers as drug delivery systems. Marcel Dekker, New York, pp. 43–70

    Google Scholar 

  6. Domb A, Bogdansky S, Olivi A, Judy K, Dureza C, Pinn ML, Colvin M, Brem H (1991) Controlled release of water soluble and hydrolytically unstable anticancer drugs from polymeric implants. Polym Prepr 32 (2): 219–220

    CAS  Google Scholar 

  7. Grossman SA, Reinhard C, Colvin OM, Chasin,M, Brundrett R, Tamargo RJ, Brem H (1992) The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. J Neurosurg 76: 640–647

    CAS  Google Scholar 

  8. Hochberg F, Pruitt A (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907–911

    PubMed  CAS  Google Scholar 

  9. Leong KW, Brott BC, Langer R (1985) Bioerodible polyanhydrides as drug-carrier matrices I: characterization, degradation, and release kinetics. J Biomed Mater Res 19: 941–955

    Article  PubMed  CAS  Google Scholar 

  10. Leong KW, D’Amore P, Marletta M, Langer R (1986) Bioerodible polyanhydrides as drug-carrier matrices II: biocompatibility and chemical reactivity. J Biomed Mater Res 20: 51–64

    Article  PubMed  CAS  Google Scholar 

  11. Olivi A, Domb A, Lenartz D, Dureza C, Goodman JH, Pinn M, Brem H (1991) Treatment of F-98 rat glioma with local controlled release of carboplatin from a biodegradable polymer. American Association of Neurological Surgeons, April 1991, New Orleans, p. 526

    Google Scholar 

  12. Tamargo RI, Epstein JI, Reinhard CS, Chasin M, Brem H (1988) Brain biocompatibility of a biodegradable controlled-release polymer in rats. J Biomed Mater Res 23: 253–266

    Article  Google Scholar 

  13. Tamargo RJ, Myseros JS, Epstein JI, Yang MB, Chasin M, Brem H (1993) Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Cancer Res 53: 329–333

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Olivi, A., Brem, H. (1994). Interstitial Chemotherapy with Sustained-Release Polymer Systems for the Treatment of Malignant Gliomas. In: Wiestler, O.D., Schlegel, U., Schramm, J. (eds) Molecular Neuro-oncology and Its Impact on the Clinical Management of Brain Tumors. Recent Results in Cancer Research, vol 135. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85039-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85039-4_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85041-7

  • Online ISBN: 978-3-642-85039-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics